Maria Luisa Biondi

About Diatech Pharmacogenetics

This author has not yet filled in any details.
So far Diatech Pharmacogenetics has created 1080 blog entries.

29 01, 2025

Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and Africa

Diatech Pharmacogenetics2025-01-29T12:10:34+01:00

20 06, 2023

Diatech Pharmacogenetics announces new collaboration to advance precision testing in oncology

Diatech Pharmacogenetics2023-06-19T18:17:17+02:00

8 06, 2023

Oncology, the ‘microenvironment’ is the super challenge of diagnostics Genomic tests are now used to create 50% of drugs. Aiming for 100%, Diatech creates the first expert board for new guidelines

Diatech Pharmacogenetics2023-06-08T10:00:16+02:00

17 05, 2023

106. Jahrestagung der Deutschen Gesellschaft für Pathologie
106. Jahrestagung der Deutschen Gesellschaft für Pathologie

Events, News

106. Jahrestagung der Deutschen Gesellschaft für Pathologie

Diatech Pharmacogenetics2024-04-29T10:14:20+02:00

26 04, 2023

Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives

Diatech Pharmacogenetics2023-04-25T20:36:11+02:00

20 05, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – April 2022

Diatech Pharmacogenetics2022-05-20T11:08:27+02:00

12 04, 2022

Monthly focus on regulatory status of new targeted therapies in oncology- March 2022

Diatech Pharmacogenetics2022-04-12T17:29:57+02:00

12 04, 2022

ALK rearrangements: a biomarker at the forefront of NSCLC treatment

Diatech Pharmacogenetics2022-04-12T12:17:10+02:00

11 04, 2022

Happy Easter 2022!
Happy Easter 2022!

News

Happy Easter 2022!

Diatech Pharmacogenetics2022-04-11T11:32:46+02:00

17 03, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology February 2022

Diatech Pharmacogenetics2022-03-24T12:38:58+01:00